BIOS Capital Management, LP Long-Term Concentrated

CIK: 0001813845 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 12, 2025

Total Value ($000): $72,575 (100.0% shares, 0.0% debt)

Holdings (6)

ACTU ACTUATE THERAPEUTICS INC 83.9%

Value ($000) $60,887 Shares 9,965,079 Est. Cost $8.16 Unrealized +7.1%

IRD OPUS GENETICS INC 4.8%

Value ($000) $3,462 Shares 3,683,429 Est. Cost $0.99 Unrealized -6.1%

LTRN LANTERN PHARMA INC 4.7%

Value ($000) $3,400 Shares 1,075,952 Est. Cost $3.42 Unrealized -1.4%

RNTX REIN THERAPEUTICS INC 3.3%

Value ($000) $2,367 Shares 1,690,751 Est. Cost $3.03 Unrealized -40.5%

CGTX COGNITION THERAPEUTICS INC 2.6%

Value ($000) $1,860 Shares 6,000,000 Est. Cost $0.49 Unrealized -31.7%

— IN8BIO INC 0.8%

Value ($000) $599 Shares 286,664 Est. Cost $0.26 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACTU	ACTUATE THERAPEUTICS INC	9,965,079	$60,887	83.9%	$8.16	+7.1%	COM	005083100
IRD	OPUS GENETICS INC	3,683,429	$3,462	4.8%	$0.99	-6.1%	COM	67577R102
LTRN	LANTERN PHARMA INC	1,075,952	$3,400	4.7%	$3.42	-1.4%	COM	51654W101
RNTX	REIN THERAPEUTICS INC	1,690,751	$2,367	3.3%	$3.03	-40.5%	COM NEW	00887A204
CGTX	COGNITION THERAPEUTICS INC	6,000,000	$1,860	2.6%	$0.49	-31.7%	COM	19243B102
—	IN8BIO INC	286,664	$599	0.8%	$0.26	—	COM	45674E109